|
|
Volumn 8, Issue 1, 2011, Pages
|
|
Patient opinions and preferences in drug development and regulatory decision making
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
NATALIZUMAB;
THALIDOMIDE;
TRASTUZUMAB;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADVANCED CANCER;
ANTIVIRAL THERAPY;
BREAST CANCER;
BREAST METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CARDIOMYOPATHY;
CROHN DISEASE;
DECISION MAKING;
DRUG APPROVAL;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
GOVERNMENT;
HEART DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KIDNEY DYSFUNCTION;
MULTIPLE MYELOMA;
MULTIPLE SCLEROSIS;
NEUROPATHY;
PATIENT ATTITUDE;
PATIENT DECISION MAKING;
PATIENT PREFERENCE;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
REGULATORY DECISION MAKING;
REVIEW;
RISK BENEFIT ANALYSIS;
TERATOGENICITY;
VEIN THROMBOSIS;
|
|
EID: 80054990436
PISSN: None
EISSN: 17406749
Source Type: Journal
DOI: 10.1016/j.ddtec.2011.03.002 Document Type: Review |
|
Times cited : (9)
|
|
References (4)
|
